- Home
- NOG vs RYTM Comparison
NOG vs RYTM Comparison
Compare NOG & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOG
- RYTM
- Stock Information
- Founded
- NOG N/A
- RYTM 2008
- Country
- NOG United States
- RYTM United States
- Employees
- NOG N/A
- RYTM N/A
- Industry
- NOG Oil & Gas Production
- RYTM Biotechnology: Pharmaceutical Preparations
- Sector
- NOG Energy
- RYTM Health Care
- Exchange
- NOG Nasdaq
- RYTM Nasdaq
- Market Cap
- NOG 3.6B
- RYTM 3.5B
- IPO Year
- NOG N/A
- RYTM 2017
- Fundamental
- Price
- NOG $33.01
- RYTM $56.07
- Analyst Decision
- NOG Strong Buy
- RYTM Strong Buy
- Analyst Count
- NOG 10
- RYTM 10
- Target Price
- NOG $47.10
- RYTM $66.90
- AVG Volume (30 Days)
- NOG 1.4M
- RYTM 380.5K
- Earning Date
- NOG 02-19-2025
- RYTM 02-26-2025
- Dividend Yield
- NOG 5.12%
- RYTM N/A
- EPS Growth
- NOG N/A
- RYTM N/A
- EPS
- NOG 5.14
- RYTM N/A
- Revenue
- NOG $2,006,670,000.00
- RYTM $112,530,000.00
- Revenue This Year
- NOG $30.00
- RYTM $66.58
- Revenue Next Year
- NOG $5.33
- RYTM $44.63
- P/E Ratio
- NOG $6.42
- RYTM N/A
- Revenue Growth
- NOG 14.87
- RYTM 81.55
- 52 Week Low
- NOG $32.81
- RYTM $35.17
- 52 Week High
- NOG $44.31
- RYTM $68.58
- Technical
- Relative Strength Index (RSI)
- NOG 29.60
- RYTM 42.18
- Support Level
- NOG $33.65
- RYTM $56.03
- Resistance Level
- NOG $36.16
- RYTM $58.65
- Average True Range (ATR)
- NOG 1.16
- RYTM 1.87
- MACD
- NOG -0.14
- RYTM -0.27
- Stochastic Oscillator
- NOG 4.91
- RYTM 5.45
About NOG Northern Oil and Gas Inc.
Northern Oil & Gas Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil and natural gas properties. Its principal business is crude oil and natural gas exploration, development, and production. Company's oil and natural gas sales come from three geographic areas in the United States: the Williston Basin (North Dakota and Montana), the Permian Basin (New Mexico and Texas), and the Appalachian Basin (Pennsylvania and Ohio).
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in development and commercialization of therapies for patients with rare diseases. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies. Geographically the company generates its revenue from the United states, Germany, and other with the majority being generated from the United states.